BioSpace News Archive

Calyptus Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) granted approval to an Abbreviated New Drug Application (ANDA) for an AP-rated generic version of Cetrotide ® (Cetrorelix Acetate for Injection, 0.25 mg/vial) to Calyptus’ partner - Akorn Operating Company LLC (“Akorn”).

CEL-SCI Corporation Announces Phase 3 Multikine ® Head and Neck Cancer Results Posted on Clinicaltrials.gov.

AIRS Medical , a healthcare startup based in South Korea and a member of the Born2Global Centre , recently announced that it has raised approximately $20M in Series B funding.

Veru Inc. today announced the appointment of Jason Davies as Executive Vice President – General Manager of Europe, the Middle East and Africa (EMEA), Latin America (LATAM), and Asia Pacific (APAC) for Veru’s Infectious Disease Franchise for Veru International.

The Preeclampsia Foundation and the Preeclampsia Foundation Canada have announced that John Snelgrove , MD, MSc, and Samantha Wilson, PhD, are their 2022 Vision Grant research award recipients respectively.

Moleculin Biotech, Inc. today reported preliminary results from the third cohort of the Company’s first-in-human Phase 1a study of WP1122.

Government of Canada officials will provide an update on COVID-19 and be available to address other public health concerns.